Cannabis use, cognitive performance, and symptoms of attention deficit/hyperactivity disorder in community adults.
Journal
Experimental and clinical psychopharmacology
ISSN: 1936-2293
Titre abrégé: Exp Clin Psychopharmacol
Pays: United States
ID NLM: 9419066
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
pubmed:
28
2
2020
medline:
13
3
2021
entrez:
28
2
2020
Statut:
ppublish
Résumé
There is some evidence that cannabis use is associated with lower cognitive performance and symptoms of attention-deficit/hyperactivity disorder (ADHD), but the existing literature is relatively inconsistent, potentially due to small samples in previous studies. Using a dimensional design, the current study examined cannabis use severity and age of first cannabis use in relation to neurocognitive performance and ADHD symptoms in a large sample of community adults (
Identifiants
pubmed: 32105137
pii: 2020-13323-001
doi: 10.1037/pha0000354
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
638-648Subventions
Organisme : NIAAA NIH HHS
ID : R01 AA024930
Pays : United States
Organisme : NIH HHS
Pays : United States